2.

for panel 1 (IMF):

• Using subgroup brands
• there are 2 types of reco share
R.share Prime & R.share Specia
CHECKED • Have 2 v/s TOTAL XX% for both
R.Share Prime & R.Share Speci
TOTAL Diabetes Brand Health Leverage (%)
(Based on total main HCPs)
Nutren DiabetCare/
Diabetes/ DiabetCare/ Diabet Care Gluvita/ Natrumax DiabetCare
Glucerna Boost Sure Diecerna DiabetCare Diamond Gluvita Gold GluCare Gold Diabet Gold/ Diabet
(Abbott) Glucose (Vinamilk) Gold (Nutifood) (VitaDairy) (Nutricare) (Deltasun) Care
Control (Nutifood) Diamond
72 (Nestle)
7 10 4 2 ▲ 0 0 (Nutifood)
0 6
Share 72 9 8 5 0 0 0
0 5
76 6 10 3 0 0 0
0 3
100 ▲ 21 ▼ 27 14 9 ▲ 0 1 ▲0 19
M Reco 99 28 23 15 3 0 0
0 15
100 21 29 14 1 0 0
0 14
100 35 ▼ 58 42 23 ▲ 1 ▲ 3 ▲0 49
r Reco 100 44 54 43 12 0 0
0 45
100 35 53 31 6 0 0
0 32

Total
100 70 ▼ 91 90 ▼ 57 29 ▲ 18 ▲ 12 ▲ 93
100 77 89 94 53 0 0
reness 100 69 89 83 38 0 0
0 94
0 86

Spont.
100 21 ▼ 39 20 10 ▲ 0 1 ▲0
100 31 33 16 5 0 0
25 ▲
reness 100 27 35 15 5 0 0
0 19
0 16
97 1 2 0 ▼ 0 0 0
TOM 96 1 1 1 0 0 0
0 0
reness 95 1 4 0 0
W2'21 0 0
0 1
(n=280) 0 0

W1'21
(n=280) Higher/Lower than previous wave at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 1
experience. W2'20 Q0/Q1/Q2/Q3ab. Awareness & Reco to Diabetes Brands
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30 (n=280)
 NOTE:
1. for panel 1 (IMF), there are 2 slid
for:
• IMF Prime brands
CHECKED • IMF Specialty brands
2. Do not show note f
TOTAL Current Reco Cases to Diabetes brands (%) Total level v/s TOTAL XX%
(Based on total HCPs who recommended specific Diabetes brands P3M)

Active reco | Recommend when asked | Approve when asked +/- active reco
Glucerna (Abbott) W1’21
(n=279) 43 35 22 0
Nutren Diabetes/ Boost Glucose Control (Nestle)
Active reco | Recommend when asked | Approve when asked
(n=59) 32 40 29 -2
Sure Diecerna (Vinamilk)
(n=76) 43 32 25 +1
W2’21 43 34 23
DiabetCare/ DiabetCare Gold (Nutifood)
(n=279) (n=38) 30 37 33 -3
CHƯA CHỈNH MỤC NÀY
Diabet Care Diamond (Nutifood)
(n=24*) 32 36 32 +7
W1’21 38 37 25DiabetCare/DiabetCare Gold/ Diabet Care Diamond
(Nutifood) 32 36 32 -2
(n=279) (N=53)
Gluvita/ Gluvita Gold (VitaDairy) 10 30 60 -
(n=1*)
GluCare Gold (Nutricare) 28 48 25 -
(n=4*)
Natrumax Diabet (Deltasun) 50 20 30 -
(n=1*)

General Practitioner/Endocrinologist/Nurse has at least 3 years * Small base, for reference only 2
Higher/Lower than previous wave at 90% c.l
experience. Q7a. Reco case to Diabetes brands
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 TOTAL W1’21
Driver Map of Factors Affecting Diabetes Recommendation
* Correlation between Reco share vs Factors using computed SPSS

OPPORTUNITIES MOTIVATORS
Correlated Importance Driving Diabetes Reco

Med Rep quality

Many support-
ing activities to High quality
HCPs Long heritage & Company that product
credible com- invests in science
pany & clinical proofs

Value for Variety of prod-

Products have money/Good ucts to support
no undesirable price for good many needs/full
side-effects quality product portfolio

LOW PRIORITY HYGIENE

Claimed Importance for Factors Driving Diabetes Reco

General Practitioner/Endocrinologist/Nurse has at least 3 years Correlation between Factors Affecting Reco to Reco Share 4
experience. Q9a. Claimed Importance for Factors Driving Reco Share
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 Data level: Total, across Reg
Specializations
Data wave: W1'20
CHECKED NOTE:
• the order of factors follow
TOTAL Factors Affecting Diabetes Recommendation (Mean Score) correlated importance 
(Based on total HCPs who are aware of specific brand) provided upon final data
Driver • For panel 3 & 4,Glucerna
pls show(Ab
& horizontal axis (major u
Index 3 5 Nutren Diabe
Med Rep quality 123% ▲ ▲ ▲ ▲ ▲ ▲ ▲▲
more important

Sure Diecerna
Many supporting activities to HCPs 111% ▲ ▲ ▲ ▲ ▲ ▲ ▲▲
DiabetCare/D
High quality product 98% ▲ ▲ ▲ ▲ ▲ ▲ ▲▲
Diabet Care D
Company that invests in science & ▲ ▲ ▲ ▲ ▲ ▲ ▲▲
96%
clinical proofs DiabetCare/ D
tifood) (n=26
Long heritage & credible company 96% ▲ ▲ ▲ ▲ ▲ ▲ ▲▲
Gluvita/ Gluv
Variety of products to support
95% ▲ ▲ ▲ ▲ ▲ ▲ ▲▲
many needs/full product portfolio
less important

GluCare Gold
Value for money/Good price for
91% ▲ ▲ ▲ ▲ ▲ ▲ ▲▲
good quality Natrumax Dia
Products have no undesirable side-
effects 89% ▲ ▲ ▲ ▲ ▲ ▲ ▲▲

Higher/Lower than previous wave at 90% c.l

Brand 1/Brand 2/Brand 3/Brand 4/Brand 5/Brand 6/Brand 7/Brand 8 smaller than [Abbott brand] at 90% c.l
Brand 1/Brand 2/Brand 3/Brand 4/Brand 5/Brand 6/Brand 7/Brand 8 larger than [Abbott brand] at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 5
experience. Q9a/Q9b. Brand Evaluation on Factors Affecting Diabetes Reco
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 • For panel 3 & 4, pls show
& horizontal axis (major u
• Do not show these brand
• Panel 3: Maxvida
CHECKED • Panel 4: Vidavance

TOTAL Factors Affecting Diabetes Recommendation (Mean Score) – W2W comparison

DiabetCare/
(Based
Nutren on total HCPs who are aware of specific brand)
Diabetes/ Diabet Care DiabetCare
Sure Diecerna DiabetCare/DiabetCare Gluvita/ Gluvita Gold GluCare G
Glucerna (Abbott) Boost Glucose Diamond Gold/ Diabet
(Vinamilk) Gold (Nutifood) (VitaDairy) (Nutrica
Control (Nestle) (Nutifood) Care Diamond
(Nutifood)
W1'21 n=280 W1'21 n=216 W1'21 n=250 W1'21 n=263 W1'21 n=149 W1'21 n=264 W1'21 n=0* W
W2'21 n=280 W2'21 n=195 W2'21 n=254 W2'21 n=252 W2'21 n=160 W2'21 n=260 W2'21 n=80 W
4.2 4.4 4.6 4.8 3.6 3.8 4 4.2 3.6 3.8 4 4.2 3.4 3.6 3.8 4 3.4 3.6 3.8 4 3.4 3.6 3.8 4 0 2 4 6 0 2
Med Rep quality

Many supporting activities to HCPs

High quality product

Company that invests in science &
clinical proofs
Long heritage & credible company

Variety of products to support many

needs/full product portfolio
Value for money/Good price for good
quality
Products have no undesirable side-effects

Higher/Lower than previous wave at 90% c.l

General Practitioner/Endocrinologist/Nurse has at least 3 years 6
Q9a/Q9b. Brand Evaluation on Factors Affecting IMF Reco
experience.
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 Data level: Total, across Regions, acr
Specializations
CHECKED Data wave: W1'20
Diabetes Brand Imagery – Absolute Score
TOTAL (Based on total main HCPs who are aware of specific brand)
NOTE:
• for panel 1 (IMF), apply for IMF Pr
0 10 20 30 40 50 60 70 80 90 100 (Q10a) only. Use next slide for IM
Provides necessary nutrition needed ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲Specialty (Q10b)
FUNCTIONAL BENEFIT

Provides complete & balanced nutrition ▲ ▲ ▲ ▲ ▲ ▲ ▲• ▲For panel 3 & 4, pls show the grid
Helps control diabetes patients’ blood sugar level ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲& horizontal axis
Can be meal replacement ▲ ▲ ▲ ▲ ▲ ▲ ▲▲
Helps to avoid craving for food ▲ ▲ ▲ ▲ ▲ ▲ ▲▲ Glucerna (Abbott) (n=280)
Gives energy
▲ ▲ ▲ ▲ ▲ ▲ ▲▲
Helps prevent cardiovascular disorders Nutren Diabetes/ Boost Glucose Contr
▲ ▲ ▲ ▲ ▲ ▲ ▲▲
Helps my patients feel less fatigued
▲ ▲ ▲ ▲ ▲ ▲ ▲▲
Boost immunity Sure Diecerna (Vinamilk) (n=254)
Value for money/Good price for good quality ▲ ▲ ▲ ▲ ▲ ▲ ▲▲
VALU

Is of high quality ▲ ▲ ▲ ▲ ▲ ▲ ▲▲ DiabetCare/*DiabetCare Gold (Nutifoo

E

Effective/works as promised ▲ ▲ ▲ ▲ ▲ ▲ ▲▲
▲ ▲ ▲ ▲ ▲ ▲ ▲▲ Diabet Care Diamond (Nutifood) (n=16
Is trustworthy
Is an expert in Healthcare Nutrition ▲ ▲ ▲ ▲ ▲ ▲ ▲▲ DiabetCare/ DiabetCare Gold/ Diabet
EQUIT

Is a brand that I recommend to my colleagues ▲ ▲ ▲ ▲ ▲ ▲ ▲▲ tifood) (n=260)

Y

Is the brand I am highly satisfied with ▲ ▲ ▲ ▲ ▲ ▲ ▲▲

I prefer my patients use this brand ▲ ▲ ▲ ▲ ▲ ▲ ▲▲ Gluvita/ Gluvita Gold (VitaDairy) (n=8
CLINIC

Brings new and innovative products ▲ ▲ ▲ ▲ ▲ ▲ ▲▲

AL

GluCare Gold (Nutricare) (n=51)

Supporting products claims with clinical studies ▲ ▲ ▲ ▲ ▲ ▲ ▲▲
Dual Effects ▲ ▲ ▲ ▲ ▲ ▲ ▲▲ Natrumax Diabet (Deltasun) (n=33)
OTH
ER

Taste good
▲ ▲ ▲ ▲ ▲ ▲ ▲▲
Simple/Easy for patients to prepare and consume
Higher/Lower than previous wave at 90% c.l Brand 1/Brand 2/Brand 3/Brand▲4/Brand
▲ ▲6/Brand
▲ ▲5/Brand ▲ ▲▲ 7/Brand 8 smaller than [Abbott brand] at 90% c.l
Brand 1/Brand 2/Brand 3/Brand ▲ ▲▲
4/Brand ▲ ▲6/Brand
5/Brand ▲ ▲ 7/Brand
▲ 8 larger than [Abbott brand] at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 7
experience. Q10. Perception on Diabetes brands (MA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 CHECKED
Diabetes Brand Imagery (%) – W2W comparison
TOTAL (Based on total
Nutren HCPs who are aware
Diabetes/ of specific brand)
DiabetCare/
DiabetCare/
Sure Diecerna Diabet Care Diamond DiabetCare Gold/ Gluvita/ Gluvita Gold G
Glucerna (Abbott) Boost Glucose Control DiabetCare Gold
(Vinamilk) (Nutifood) Diabet Care Diamond (VitaDairy)
(Nestle) (Nutifood)
(Nutifood)
W1'21 n=280 W1'21 n=216 W1'21 n=250 W1'21 n=263 W1'21 n=149 W1'21 n=264 W1'21 n=0*
W2'21 n=280 W2'21 n=195 W2'21 n=254 W2'21 n=252 W2'21 n=160 W2'21 n=260 W2'21 n=80
92 94 96 98 100 20 30 40 50 60 25303540455055 10152025303540 0 5 1015202530 0 10 20 30 40 50 0 5 1015202530
FUNCTIONAL BENEFIT

Provides necessary nutrition needed

Provides complete & balanced nutrition
Helps control diabetes patients’ blood sugar level
Can be meal replacement
Helps to avoid craving for food
Gives energy
Helps prevent cardiovascular disorders
Helps my patients feel less fatigued
Boost immunity
VALU

Value for money/Good price for good quality

E

Is of high quality
Effective/works as promised
Is trustworthy
EQUIT

Is an expert in Healthcare Nutrition

Y

Is a brand that I recommend to my colleagues

Is the brand I am highly satisfied with
I prefer my patients use this brand
OTHE CLINIC

Brings new and innovative products

AL

Supporting products claims with clinical studies

Dual Effects
Taste good
R

Simple/Easy for patients to prepare and consume

General Practitioner/Endocrinologist/Nurse has at least 3 years * Small base, for reference only 8
experience. Higher/Lower than previous wave at 90% c.l Q10. Brand imagery (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 NOTE: for panel 1 (IMF), the
slides for:
• IMF Prime brands
• IMF Specialty brands
Diabetes Brand Imagery – Standardize Score
TOTAL (Based on total HCPs who are aware of specific brand)
Nutren Diabetes/ DiabetCare/ Diabet Care
Sure Diecerna Gluvita/ Gluvita GluCare Gold Natrumax Diabe
Glucerna (Abbott) Boost Glucose *DiabetCare Gold Diamond
(Vinamilk) Gold (VitaDairy) (Nutricare) (Deltasun)
Control (Nestle) (Nutifood) (Nutifood)
(n=280) (n=195) (n=254) (n=252) (n=160) (n=80) (n=51) (n=33)

Provides necessary nutrition needed -4 4 1 0 -1 3 -2 0

-6 0
FUNCTIONAL BENEFIT

Provides complete & balanced nutrition -1 3 0 6 1 -2

Helps control diabetes patients’ blood sugar level -7 -1 2 3 3 2 -7 0
Can be meal replacement 6 -2 1 -2 -2 2 0 0
Helps to avoid craving for food -12 3 0 0 3 -2 3 0
Gives energy -6 0 4 1 0 -1 2 0
Helps prevent cardiovascular disorders 2 -2 -1 -3 0 4 3 0
Helps my patients feel less fatigued 2 2 -6 1 -2 -1 0
Boost immunity -11 0 -1 -1 -1 1 8 0
Value for money/Good price for good quality -1 6 4 3 0 0 -8 0
Is of high quality 6 -2 -4 -4 0 7 1 0
VALU

9 0 -1 -1 0 -6 0 0
E

Effective/works as promised
Is trustworthy -5 6 0 -1 1 0 4 0
Is an expert in Healthcare Nutrition 0 -5 0 2 0 0 1 0
Is a brand that I recommend to my colleagues 1 -4 -3 -2 0 -1 7 0
EQUIT

Is the brand I am highly satisfied with 13 -5 -3 0 -2 -3 -3 0

Y

I prefer my patients use this brand 7 0 -1 -2 1 -1 0 0

Brings new and innovative products 3 0 -6 -1 4 -1 5 0
Supporting products claims with clinical studies 0 2 2 1 0 -2 -3 0
OTHE CLINIC

0 0
AL

Dual Effects 9 -4 0 -3 -3 -2
Taste good 8 2 0 3 -5 -3 -2 0
Simple/Easy for patients to prepare and consume -18 -3 3 6 -1 6 0 0
R

General Practitioner/Endocrinologist/Nurse has at least 3 years 9

experience. Q10. Perception on Diabetes brands (MA)
STDEV.P 3.97
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 Data level: Total, across spe
Data wave: W1'20
CHECKED NOTE: for panel 1 (IMF), usin
brands
TOTAL Diabetes Med Rep Recall (%)
(Based on total HCPs who was visited by any med rep in P3M)

P3M Visit Frequency Visit Length

Med Rep Recall (%)
(times) (mins)
+/- TOM +/- T.Recall Current +/- vs Current +/- vs
TOM Unaided Total recall
vs W1’21 Vs. W1’21 W2’21 W1’21 W2’21 W1’21

Glucerna (Abbott) 98 100 100 +2 0 N=280 2.4 -0.9 11.1 +1.1

Nutren Diabetes/ Boost

Glucose Control (Nestle) 1 18 20 0 -9 N=56 2.9 +0.4 9.4 -0.2

Sure Diecerna (Vinamilk) 2 26 28 +1 +6 N=77 2 -0.7 12.1 +1.6

DiabetCare/ DiabetCare
Gold/ Diabet Care Diamond 0 15 19 - - N=53 12.6 +1.6
2.4 -1.6
(Nutifood)
01 1 0 +1 N=4*
Gluvita/ Gluvita Gold 1.8 - 6.3 -
(VitaDairy)
0 3 0 +3
GluCare Gold (Nutricare) N=7* 1.7 - 11.4 -

0 0 0 0
Natrumax Diabet (Deltasun) N=0* - - -
-
General Practitioner/Endocrinologist/Nurse has at least 3 years Higher/Lower than previous wave at 90% c.l S12a/S12/S13. Med Rep Recall from Diabetes Brand 10
experience. Q12/Q13. Visit Frequency/Visit Length
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 CHECKED NOTE: for panel 1 (IMF),
Diabetes Med Rep Recall (%) using subgroup brands
BY REGION (Based on total main HCPs)
OTHER SOUTH CENTRAL OTHER NORTH

TOTAL HCM-R1 HN-R7 R2 R3 R4 R5 R6 R8

W2'21 n=280 W2'21 n=50 W2'21 n=50 W2'21 n=30 W2'21 n=30 W2'21 n=30 W2'21 n=30 W2'21 n=30 W2'21 n=30
W1'21 n=280 W1'21 n=50 W1'21 n=50 W1'21 n=30 W1'21 n=30 W1'21 n=30 W1'21 n=30 W1'21 n=30 W1'21 n=30
Glucerna (Abbott) 100 100 100 100 100 100 100 100 100
100 100 100 100 100 100 100 100 100
iabetes/ Boost Glucose
Control (Nestle) 29 52 22 43 17 0 7 27 53
20 ▼ 42 16 43 3 ▼ 0 0 20 23 ▼
ure Diecerna (Vinamilk) 22 18 14 7 13 23 53 47 10
28 38 ▲ 12 0 20 33 53 53 13
tCare/DiabetCare Gold 16 20 18 3 10 60 0 17 0
(Nutifood) 18 24 16 0 3 63 10 ▲ 23 0
5 8 18 0 3 0 0 3 0
re Diamond (Nutifood) 8 18 16 0 3 0 7 7 0
17 20 18 3 13 60 0 17 0
Care/DiabetCare Gold/ 19 28 16 0 3 63 10 ▲ 27 0
re Diamond (Nutifood)
0 0 0 0 0 0 0 0 0
Gluvita Gold (VitaDairy) 1 ▲ 6 ▲ 2 0 0 0 0 0 0
uCare Gold (Nutricare)
0 0 0 0 0 0 0 0 0
3 ▲ 4 6 ▲ 0 3 0 0 3 0
0 0 0 0 0 0 0 0 0
umax Diabet (Deltasun) 0 0 0 0 0 0 0 0 0

General Practitioner/Endocrinologist/Nurse has at least 3 years Higher/Lower than previous wave at 90% c.l
11
experience. S12a/S12/S13. Med Rep Recall from Diabetes Brand
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 IMF only
• General practitioner and
Endocrinologist for panel 4
CHECKED
W2’21 TOTAL DOCTORS NON-DOCTOR GP Endocrinologist
(n=280) vs W1'21 (n=210) vs W1'21 (n=70) vs W1’21 (n=71) vs W1'21 (n=139) vs W1'21
Glucerna 97-1 99+0 96 -2 98 -1 99+1
Nutren Diabetes 1 0 0 0 1 0 1 +1 0 -1
Sure Diecerna 2 +1 1 0 3 +3 1 0 1 0
Share of
DiabetCare/DiabetCare Gold 0 0 0 0 0 -1 0 0 0 0
Voice (%)Diabet Care Diamond 0 0 0 0 0 0 0 0 0 0
Gold/ Diabet Care Diamond (Nutifood) 0 0 0 0 0 0 0 0 0 0
= TOM Recall
Gluvita/ Gluvita Gold 0 0 0 0 0 0 0 0 0 0
GluCare Gold 0 0 0 0 0 0 0 0 0 0
Natrumax Diabet 0 0 0 0 0 0 0 0 0 0

Glucerna 56 58 52 58 58
-2 0 -4 -7 +2
Nutren Diabetes 11 12 10 12 -8 ▼
-6 ▼ -5 -7 +1 12
Sure Diecerna 16 +3 16 +2 15 +4 13 +3 +2
Share of 17
DiabetCare/DiabetCare Gold 10 +1 9 +1 12 +1 9 -1 +1
Visit (%) 10
Diabet Care Diamond 4 +2 3 +1 7 +3 5 -1 +1
3
Gold/ Diabet Care Diamond (Nutifood) 0 0 0 0 0 0 0 0 0
= Total recall *
Gluvita/ Gluvita Gold 1 +1 1 +1 2 +2 1 +1 1 +1
Visit Frequency 1
GluCare Gold 2 +2 ▲ 1 +1 2 +2 3 +3 +1
Natrumax Diabet 0 0 0 0 0 0 0 0 0 0

General Practitioner/Endocrinologist/Nurse has at least 3 years S12a/S13. Med Rep Recall from Diabetes Brand 12
experience. Q12. Visit Frequency
Higher/Lower than previous wave at 90% c.l
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 CHECKED
W2’21 TOTAL HCMC (R1) HANOI (R7) R2 R5
(n=280) vs W1'21 (n=50) vs W1'21 (n=50) vs W1'21 (n=30) vs W1'21 (n=30) vs W1'21
Glucerna 97-1 94 -4 100 0 97 +4 97 -3
Nutren Diabetes 1 0 2 +2 0 0 3 -4 0 0
Sure Diecerna 2 +1 4 +4 0 0 0 0 3 +3
Share of
DiabetCare/DiabetCare Gold 0 0 0 -2 0 0 0 0 0 0
Voice (%) Diabet Care Diamond 0 0 0 0 0 0 0 0 0 0
re Gold/ Diabet Care Diamond (Nutifood) 0 0 0 0 0 0 0 0 0 0
= TOM RecallGluvita/ Gluvita Gold 0 0 0 0 0 0 0 0 0 0
GluCare Gold 0 0 0 0 0 0 0 0 0 0
Natrumax Diabet 0 0 0 0 0 0 0 0 0 0

Glucerna 56 -2 43 -7 60 +1 70 +5 59 -4
Nutren Diabetes 11 -6 ▼ 18 -8 10 -3 30 +2 0 -4
Sure Diecerna 16 +3 16 +7 7 -1 0 -5 31 -2
Share of
DiabetCare/DiabetCare Gold 10 +1 10 +0 10 -1 0 -2 6 +6
Visit (%)
Diabet Care Diamond 4 +2 8 +4 10 -1 0 0 4 +4
e Gold/ Diabet Care Diamond (Nutifood) 0 0 0 0 0 0 0 0 0 0
= Total recall Gluvita/
* Gluvita Gold 1 +1 3 +3 1 +1 0 0 0 0
Visit Frequency
GluCare Gold 2 +2 ▲ 2 +2 4 +4 0 0 0 0
Natrumax Diabet 0 0 0 0 0 0 0 0 0 0
General Practitioner/Endocrinologist/Nurse has at least 3 years S12a/S13. Med Rep Recall from Diabetes Brand 13
experience. Q12. Visit Frequency
Higher/Lower than previous wave at 90% c.l
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 CHECKED
W2’21 TOTAL R3 R4 R6 R8
(n=280) vs W1'21 (n=30) vs W1'21 (n=30) vs W1'21 (n=30) vs W1'21 (n=30) vs W1'21
Glucerna 97-1 100 0 97 +5 97 0 100 0
Nutren Diabetes 1 0 0 0 0 0 0 0
0 0
Sure Diecerna 2 +1 0 0 3 3 0 0 0
-5
Share of
DiabetCare/DiabetCare Gold 0 0 0 0 0 0 0 0 0 0
Voice (%) Diabet Care Diamond 0 0 0 0 0 0 0 0 0 0
re Gold/ Diabet Care Diamond (Nutifood) 0 0 0 0 0 0 0 0 0 0
= TOM RecallGluvita/ Gluvita Gold 0 0 0 0 0 0 0 0 0 0
GluCare Gold 0 0 0 0 0 0 0 0 0 0
Natrumax Diabet 0 0 0 0 0 0 0 0 0 0

Glucerna 56 -2 76 +6 51 -4 49 -3 74 +12
-6 ▼ 2 -10 0 0 10 -4 17 -16
Nutren Diabetes 11
Sure Diecerna +3 15 +6 17 +4 26 +2 10 +3
Share of 16
DiabetCare/ +1 2 -5 32 -1 11 +2 0 0
Visit (%) 10
DiabetCare Gold +2 2 0 0 0 3 +2 0 0
Diabet Care 4 0
Diamond 0 0 0 0 0 0 0 0
= Total recall * 1 +1 0 0 0 0 0 0 0 0
Visit Frequency Gluvita/ Gluvita
Gold 2 +2 ▲ 2 +2 0 0 1 +1 0 0
GluCare Gold 0 0 0 0 0 0 0 0 0 0
Natrumax Diabet
General Practitioner/Endocrinologist/Nurse has at least 3 years S12a/S13. Med Rep Recall from Diabetes Brand 14
experience. Q12. Visit Frequency
Higher/Lower than previous wave at 90% c.l
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 •
correlated importance  to be
provided upon final data
• For panel 3 & 4, pls show the grid
CHECKED & horizontal axis (major unit = 0.5

TOTAL Diabetes Med Rep Evaluation (Mean score)

(Based on total main HCPs who got visited in P3M by specific companies’ med rep)
Driver
Index 3.00 5.00
OVERALL MR SATISFACTION ▲▲
Glucerna (Abbott) (n=280)
Engages me in product discussion 106%
more important

▲
Nutren Diabetes/ Boost Glucose
Persuasive detailing 105% ▲▲ (Nestle) (n=56)
Trustworthy 104% ▲▲ Sure Diecerna (Vinamilk) (n=77)
Clear, well-structured brand messages 104% ▲▲ DiabetCare/ DiabetCare Gold/ Di
Well-equipped with scientific data 103%
Care Diamond (Nutifood) (n=53)
▲▲
Knowledge about products & competitors 100% ▲▲
Gluvita/ Gluvita Gold (VitaDairy)

Have in-depth nutritional knowledge

less important

99% ▲ GluCare Gold (Nutricare) (n=7)

Appropriate frequency of visits 97% ▲▲ Natrumax Diabet (Deltasun) (n=0

Courteous 83% ▲▲

Higher/Lower than previous wave at 90% c.l Brand 1/Brand 2/Brand 3/Brand 4/Brand 5/Brand 6 smaller than Abbott at 90% c.l
Brand 1/Brand 2/Brand 3/Brand 4/Brand 5/Brand 6 larger than Abbott at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 15
experience. 15
Q14. Med Rep Evaluation (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 • For panel 3 & 4:
• pls show the gridline &
horizontal axis (major unit =
CHECKED
TOTAL DiabetesNutren
Glucerna
(Abbott)
Med Rep Evaluation
Diabetes
(Nestle)
Sure Diecerna(Mean
(Vinamilk)
score)
DiabetCare/
DiabetCare Gold/
Gluvita/ Gluvita Gold GluCare Gold Na
(Based on total main HCPs who got visited in P3M by specific Diabet Care med rep)
companies’ (VitaDairy) (Nutricare)
Diamond
(Nutifood)

W1'21 n=280 W1'21 n=81 W1'21 n=62 W1'21 n=47 W1'21 n=0* W1'21 n=0*
W2'21 n=280 W2'21 n=56 W2'21 n=77 W2'21 n=53 W2'21 n=4* W2'21 n=7*

4.20 4.30 4.40 4.50 4.60

3.00 3.50 4.00 4.50
4.00 4.10 4.20 4.30 4.40
4.00 4.20 4.40 4.60 4.80
0.001.002.003.004.005.00
0.001.002.003.004.005.00
0.000.2
OVERALL MR SATISFACTION
Engages me in product discussion
Persuasive detailing
Trustworthy
Clear, well-structured brand messages
Well-equipped with scientific data
Knowledge about products & competitors
Have in-depth nutritional knowledge
Appropriate frequency of visits
Courteous

* Small base, for reference only

General Practitioner/Endocrinologist/Nurse has at least 3 years
Higher/Lower than previous wave at 90% c.l Q14. Med Rep Evaluation (SA) 16
experience.
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 Data level: Total
NOTE: for panel 1 (IMF), the
slides for:
Similac IQ HMO
Similac Total Comfort
Similac Neo Sure
TOTAL Med Rep’s Spontaneous Key Messages – Glucerna (%)
(Based on total HCPs who got visited by Glucerna med rep)

W2’20 W1’21
(n=280) (n=280)

Relevance score 4.69 4.77

Stabilize blood sugar 76 84 ▲
DV: Not automated as the attributes are in Vietnamese, it
Provide nutrition 48 47
couldn’t be matched.
For diabetics/ good for diabetics/ glycemic disorders 40 41

Enhance cardiovascular health 28 24

Strengthen health/ Revive health 17 16

Replace meal 14 13

Higher/Lower than previous wave at 90% c.l

General Practitioner/Endocrinologist/Nurse has at least 3 years Q5c.Med Rep’s Key Message Relevance (SA) 17
experience. Q5b. Key Message from Med Rep(Spontaneous) (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 NOTE: for panel 1 (IMF), the
slides for:
IMF Prime brands
IMF Specialty brands
Med Rep’s Key Messages – Standardize Score (%)
Message for Glucerna (Based on total HCPs who got visitedNutren
in P3M by specific
Sure companies’ med rep)
Diabetes/ DiabetCare/ Diabet Care
TOTAL Message for Nutren Diabetes Diecerna
Glucerna (Abbott) Boost Glucose *DiabetCare Gold Diamond
(Vinamilk)
Control (Nestle) (Nutifood) (Nutifood)
Message for Sure Diecerna (n=280) (n=56) (n=77) (n=50) (n=22*)
Message for Diabetcare

Dual Effects - proven to help stabilize blood glucose effectively 2 0 -7 1 4

Support heart health due to rich in MUFA, Omega-3 0 4 -7 3 -1

Provide 35 nutrients to meet the C&B nutrients need for people with diabetes 2 -5 0 7 -5

Improve blood glucose within 4 hours and control blood glucose in term-use with
1.1% HbA1C in 6 months -2 -4 3 -1 3

Can be meal replacement 10 0 -2 0 -8

Low Glycemic Index, contain 100% Isomaltulose, rich in Whey protein, rich in
fiber, good fat blended (MUFA & PUFA) -2 -6 6 -7 8

High amount of Myo-Inositol (800mg/serving), proven to reduce insulin resistance 1 8 -2 -2 -5

Stabilize blood glucose level better than standard oral formula with Low Glycemic
Index for effective blood glucose control (GI = 27.6) & prevent complication -9 -9 13 -3 7
Low GI and carenutrition nutrients that helps boost immunity, good for heart
health, prevent constipation, reduce osteoporosis, manage body weight 1 -2 3 3 -5
CRich in whey and Isomaltulose help increase insulin secretion support to reduce
post prandial blood glucose -4 14 -8 -1 0

General Practitioner/Endocrinologist/Nurse has at least 3 years 18

experience. STDEV.P 5.4 Q5d. Med Rep’s Aided Key Message (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
Strong points Neutral Weak points
 slides for:
IMF Prime brands
IMF Specialty brands
CHECKED
Med Rep’s Key Messages – Absolute Score (%)
Message for Glucerna Nutren
(Based on total HCPs who got visited in P3M by specific companies’
DiabetCare/ med rep)
DiabetCare/
TOTAL Message for Nutren Diabetes Glucerna
Diabetes/
Sure Diecerna *DiabetCare
Diabet Care DiabetCare Gluvita/
GluCare Gold
Natrumax
Boost Glucose Diamond Gold/ Diabet Gluvita Gold Diabet
Message for Sure Diecerna (Abbott) (Vinamilk) Gold (Nutricare)
Control (Nutifood) Care Diamond (VitaDairy) (Deltasun)
(Nutifood)
Message for Diabetcare (Nestle) (Nutifood)
(n=280) (n=56) (n=77) (n=50) (n=22*) (n=53) (n=4*) (n=7*) (n=0*)
Dual Effects - proven to help stabilize blood glucose effectively 88 16 17 8 15 18 0 0 0

Support heart health due to rich in MUFA, Omega-3 88▲ 21 ▼ 17 10 15 14 0 0 0

Provide 35 nutrients to meet the C&B nutrients need for people with diabetes 86 11 ▼ 23 14 17 9 25 0 0
Improve blood glucose within 4 hours and control blood glucose in term-use with 27 18
1.1% HbA1C in 6 months 86 13 6 13 0 29 0

Can be meal replacement 86 14 19 6 8 5 0 0 0

Low Glycemic Index, contain 100% Isomaltulose, rich in Whey protein, rich in 30 23
fiber, good fat blended (MUFA & PUFA) 86 11 ▼ 0 ▼ 9 0 0 0

High amount of Myo-Inositol (800mg/serving), proven to reduce insulin resistance 83 23 21 4 8 9 0 0 0

Stabilize blood glucose level better than standard oral formula with Low Glycemic 39 4 23
Index for effective blood glucose control (GI = 27.6) & prevent complication 85 9 ▼ 13 0 0 0
Low GI and carenutrition nutrients that helps boost immunity, good for heart 27 10 9
health, prevent constipation, reduce osteoporosis, manage body weight 86 14 13 0 0 0
CRich in whey and Isomaltulose help increase insulin secretion support to reduce 16 6 14
post prandial blood glucose 83▲ 30 11 0 14 0

General Practitioner/Endocrinologist/Nurse has at least 3 years Higher/Lower than previous wave at 90% c.l 19
experience. Q5d. Med Rep’s Aided Key Message (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30 Outstanding key message among that specific brands
 • Panel 3: Maxvida
• Panel 4: Vidavance

CHECKED
Med Rep’s Key Messages – W2W Comparison (%)
Message for Glucerna (Based on total HCPs who
Nutren got visitedSure
Diabetes/ in P3M by specific companies’Diabet
DiabetCare/ med rep) DiabetCare/
TOTAL Message for Nutren Diabetes Glucerna (Abbott) Boost Glucose
Diecerna
DiabetCare Gold
Care Diamond DiabetCare Gold/ Gluvita/ Gluvita Gold Glu
(Vinamilk) (Nutifood) Diabet Care Diamond (VitaDairy) (N
Control (Nestle) (Nutifood)
Message for Sure Diecerna (Nutifood)
Message for Diabetcare
W1'21 n=280 W1'20 n=199 W1'21 n=62 W1'21 n=46 W1'21 n=15* W1'21 n=47 W1'21 n=0*
W2'21 n=280 W2'20 n=186 W2'21 n=77 W2'21 n=50 W2'21 n=22* W2'21 n=53 W2'21 n=4*
60 70 80 90 0 10 20 30 40 50 10 20 30 40 50 0 5 10 15 20 25 0 10 20 30 0 10
Dual Effects - proven to help stabilize blood glucose effectively

Support heart health due to rich in MUFA, Omega-3

Provide 35 nutrients to meet the C&B nutrients need for people with
diabetes

Improve blood glucose within 4 hours and control blood glucose in term-
use with 1.1% HbA1C in 6 months

Can be meal replacement

Low Glycemic Index, contain 100% Isomaltulose, rich in Whey protein,

rich in fiber, good fat blended (MUFA & PUFA)

High amount of Myo-Inositol (800mg/serving), proven to reduce insulin

resistance

Stabilize blood glucose level better than standard oral formula with Low
Glycemic Index for effective blood glucose control (GI = 27.6) & prevent
complication
Low GI and carenutrition nutrients that helps boost immunity, good for
heart health, prevent constipation, reduce osteoporosis, manage body
weight

CRich in whey and Isomaltulose help increase insulin secretion support

to reduce post prandial blood glucose

General Practitioner/Endocrinologist/Nurse has at least 3 years * Small base, for reference only 20
experience. Higher/Lower than previous wave at 90% c.l Q5d. Med Rep’s Aided Key Message (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 Data level: Total, across Regions, across
specialization
CHECKED
TOTAL Ethical Activities P3M Participation (%)
(Based on main HCPs)

Driver Index
Scientific symposia ( Vietnamese 11
presenters) 358% 15
more important 12
Scientific symposia 358% 15
8
Hospital symposia 150% 5
4
Small meetings 150% 3
4
Brand reminders 124% 2
2 W2'21 (n=280)
Product sampling (milk) 99% 1
Scientific symposia held by 0 W1'21 (n=280)
99% 1
associations 4
Group presentation to HCPs 83%
3
1
Patients screenings 74%
1
1
Scientific symposia ( foreign 1
64% 2
presenters)
1
Patients education 47% 0
0
Oversea congress 1
less important

0%
1
Clinical research programs 0% 0
0
Outing workshop 0% 76
77
General Practitioner/Endocrinologist/Nurse has at least 3 years
None 358%
experience. Higher/Lower than previous wave at 90% c.l Q16. Ethical Activities Sponsorship 21
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 Data wave: W1'20
NOTE: the order of activites follow
CHECKED correlated importance  to be pr
upon final data
TOTAL Ethical Activities by Company Sponsorship (%)
(Based on main HCPs)
Abbott Nestle Vinamilk Nutifood VitaDairy Nutricare De
Base
more important

Scientific symposia ( Vietnamese presenters) 41 88 15 0 0 0 0 0

Scientific symposia 42 88
Hospital symposia 13 54
Small meetings 8 100
Brand reminders 5 100
Product sampling (milk) 2 100
Scientific symposia held by associations 4 50
Group presentation to HCPs 7 43
Patients screenings 3 67
Scientific symposia ( foreign presenters) 2 100
Patients education 2 100
0 0
less important
14 0 0 0 0 0
0 8 0 0 0 0
0 0 0 0 0 0
0 0 20 20 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0
0 0 14 0 0 0
0 0 33 0 0 0
0 0 0 0 0 0
0 0 50 50 50 0
0 0 0 0 0 0

Oversea congress

Clinical research programs 3 0 0 0 0 0 0 0

Outing workshop 0 0 0 0 0 0 0 0

General Practitioner/Endocrinologist/Nurse has at least 3 years Higher/Lower than previous wave at 90% c.l * Small base, for reference only
experience. Q16. Ethical Activities Sponsorship 22
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 Data level: Total, across Reg
specialization
Data wave: W1'20
CHECKED NOTE: the order of activites
TOTAL Ethical Activities by Company Satisfaction (mean score) correlated importance  to
upon final data
(Based on main HCPs *)
Abbott Nestle Vinamilk Nutifood VitaDairy Nutricare Deltasun

Scientific symposia ( Vietnamese presenters) 4.31 4.00 - - - - -

Scientific symposia 4.27 4.00 - - - - -
Hospital symposia 4.00 - 5.00 - - - -
Small meetings 4.38 - - - - - -
Brand reminders 4.00 - - 5.00 5.00 - -
Product sampling (milk) 4.00 - - - - - -
Scientific symposia held by associations 4.50 - - - - - -
Group presentation to HCPs 4.33 - - 5.00 - - -
Patients screenings 4.00 - - 3.00 - - -
Scientific symposia ( foreign presenters) 4.00 - - - - - -
Patients education 5.00 - - 5.00 5.00 5.00 -
Clinical research programs - - - - - - -
Outing workshop - - - - - - -
Higher/Lower than previous wave at 90% c.l

General Practitioner/Endocrinologist/Nurse has at least 3 years * Small base, for reference only
experience. Q17. Ethical Activities & Evaluation 23
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 Data wave: W1'20
Note:
CHECKED • Panel 1 get reco share
• Calculate Ethical Effecti
Reco share / MR reach
TOTAL Changes in Reco Share & Overlap of Med Rep Recall (%)
(Based on main HCPs)

ETHICAL EFFECTIVENESS
72% 72 72 33% 36% 23% 25% 4% 10% - W2'21 (n=280)
W1'21 (n=280)
INDEX
(Recoshare/MR reach)
Chưa tính lại chỉ số này
9 7 8 10 5 4 0 2 5 6 0 0 0 0 0 0
Series1

72% 32% 35% 29% 9% -% -% -%

RECO
SHARE

100
100

29 20 22 28 16 18 17 19
5 8 0 1 0 3 0 0

MEDREP
RECALL

General Practitioner/Endocrinologist/Nurse has at least 3 years S13. Med Rep Recall from [Abbott] Brand 24
experience. Q3. Reco share
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 axis, scale 3-5 (major unit = 0.5)

Replicate for all brands – across panels

CHECKED
Factors Affecting ANS Recommendation (Mean Score) – Glucerna across regions
(Based on total HCPs who are aware of ANS brand)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5
Med Rep quality ▼ ▲ ▲ ▼

Many supporting activities to HCPs ▲ ▼

High quality product ▼ ▲ ▲ ▲ ▲ ▼

Company that invests in science & clinical

proofs ▲ ▲ ▼

Long heritage & credible company ▲ ▲ ▼

Variety of products to support many
needs/full product portfolio ▼ ▲ ▼ ▲ ▲ ▼
Value for money/Good price for good
quality ▼ ▲ ▲ ▼ ▲ ▲ ▼

Products have no undesirable side-effects

▼ ▲ ▲ ▲ ▼
Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than total at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 25
experience. Q9b. Brand Evaluation on Factors Affecting ANS Reco
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 axis, scale 3-5 (major unit = 0.5)

Replicate for all brands – across panels

CHECKED
Factors Affecting ANS Recommendation (Mean Score) – Nutren Diabetes across regions
(Based on total HCPs who are aware of ANS brand)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5

Med Rep quality

▼

Many supporting activities to HCPs ▲ ▼

High quality product ▲

Company that invests in science & clinical

proofs ▲

Long heritage & credible company

Variety of products to support many

needs/full product portfolio
Value for money/Good price for good
quality

Products have no undesirable side-effects

Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than total at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 26
experience. Q9b. Brand Evaluation on Factors Affecting ANS Reco
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 axis, scale 3-5 (major unit = 0.5)

Replicate for all brands – across panels

CHECKED
Factors Affecting ANS Recommendation (Mean Score) – Sure Diecerna across regions
(Based on total HCPs who are aware of ANS brand)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5

Med Rep quality

▼ ▲

Many supporting activities to HCPs ▼ ▲ ▼

High quality product ▲ ▼

Company that invests in science & clinical ▲ ▼

proofs

Long heritage & credible company ▲ ▼

Variety of products to support many

needs/full product portfolio ▲ ▼
Value for money/Good price for good
quality ▲ ▼

Products have no undesirable side-effects ▲ ▼

Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than total at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 27
experience. Q9b. Brand Evaluation on Factors Affecting ANS Reco
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 axis, scale 3-5 (major unit = 0.5)

Replicate for all brands – across panels

CHECKED
Factors Affecting ANS Recommendation (Mean Score) – DiabetCare/ DiabetCare Gold across
regions
(Based on total HCPs who are aware of ANS brand)

HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5

Med Rep quality ▼

Many supporting activities to HCPs ▼

High quality product ▼

Company that invests in science & clinical

proofs

Long heritage & credible company ▼

Variety of products to support many
needs/full product portfolio ▼
Value for money/Good price for good
quality ▼

Products have no undesirable side-effects

Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than total at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 28
experience. Q9b. Brand Evaluation on Factors Affecting ANS Reco
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 axis, scale 3-5 (major unit = 0.5)

Replicate for all brands – across panels

CHECKED
Factors Affecting ANS Recommendation (Mean Score) – Diabet Care Diamond regions
(Based on total HCPs who are aware of ANS brand)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5

Med Rep quality

▼

Many supporting activities to HCPs

High quality product ▼

Company that invests in science & clinical

proofs

Long heritage & credible company ▼

Variety of products to support many

needs/full product portfolio
Value for money/Good price for good
quality

Products have no undesirable side-effects ▼

Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than total at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 29
experience. Q9b. Brand Evaluation on Factors Affecting ANS Reco
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 axis, scale 3-5 (major unit = 0.5)

Replicate for all brands – across panels

CHECKED
Factors Affecting ANS Recommendation (Mean Score) – DiabetCare/ DiabetCare Gold/ Diabet
Care
(Based on totalDiamond
HCPs who areacross
aware of regions
ANS brand)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5

Med Rep quality ▼

Many supporting activities to HCPs ▼ ▼ ▼

High quality product ▼ ▼

Company that invests in science & clinical

proofs

Long heritage & credible company ▼ ▼

Variety of products to support many

needs/full product portfolio ▼ ▼
Value for money/Good price for good
quality ▼ ▼

Products have no undesirable side-effects ▼

▼
Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than total at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 30
experience. Q9b. Brand Evaluation on Factors Affecting ANS Reco
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 axis, scale 3-5 (major unit = 0.5)

Replicate for all brands – across panels

CHECKED
Factors Affecting ANS Recommendation (Mean Score) – Gluvita/ Gluvita Gold across regions
(Based on total HCPs who are aware of ANS brand)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5

Med Rep quality

Many supporting activities to HCPs

High quality product

Company that invests in science & clinical

proofs

Long heritage & credible company

Variety of products to support many

needs/full product portfolio
Value for money/Good price for good
quality

Products have no undesirable side-effects

Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than total at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 31
experience. Q9b. Brand Evaluation on Factors Affecting ANS Reco
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 • For panel 3 & 4, pls show horizontal
axis, scale 3-5 (major unit = 0.5)
CHECKED
ANS Med Rep Evaluation (Mean score) – Abbott MR across regions
(Based on total main HCPs who got visited in P3M by ANS med rep)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5
OVERALL MR SATISFACTION ▲ ▲ ▼
Engages me in product discussion ▼ ▲ ▼

Persuasive detailing ▲ ▼

Trustworthy ▲ ▲ ▼
Clear, well-structured brand messages ▼ ▲ ▲ ▼
Well-equipped with scientific data ▲ ▲ ▼
Knowledge about products & ▲ ▲ ▼
competitors ▼ ▲
▲ ▼
Have in-depth nutritional knowledge
▲ ▼
Appropriate frequency of visits
▲ ▲ ▼
Courteous
Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than previous wave at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years
experience. 32
Q14. Med Rep Evaluation (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 • For panel 3 & 4, pls show horizontal
axis, scale 3-5 (major unit = 0.5)
CHECKED
ANS Med Rep Evaluation (Mean score) – Nestle MR across regions
(Based on total main HCPs who got visited in P3M by ANS med rep)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5
OVERALL MR SATISFACTION
Engages me in product discussion
Persuasive detailing
Trustworthy
Clear, well-structured brand messages
Well-equipped with scientific data
Knowledge about products &
competitors
Have in-depth nutritional knowledge

Appropriate frequency of visits

Courteous
Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than previous wave at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years
experience. 33
Q14. Med Rep Evaluation (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 • For panel 3 & 4, pls show horizontal
axis, scale 3-5 (major unit = 0.5)
CHECKED
ANS Med Rep Evaluation (Mean score) – Vinamilk MR across regions
(Based on total main HCPs who got visited in P3M by ANS med rep)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5
OVERALL MR SATISFACTION
Engages me in product discussion
Persuasive detailing
Trustworthy
Clear, well-structured brand messages
Well-equipped with scientific data
Knowledge about products &
competitors
Have in-depth nutritional knowledge
Appropriate frequency of visits
Courteous
Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than previous wave at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years
experience. 34
Q14. Med Rep Evaluation (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 • For panel 3 & 4, pls show horizontal
axis, scale 3-5 (major unit = 0.5)
CHECKED
ANS Med Rep Evaluation (Mean score) – Nutifood MR across regions
(Based on total main HCPs who got visited in P3M by ANS med rep)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5
OVERALL MR SATISFACTION
Engages me in product discussion
Persuasive detailing
Trustworthy
Clear, well-structured brand messages
Well-equipped with scientific data
Knowledge about products &
competitors
Have in-depth nutritional knowledge
Appropriate frequency of visits
Courteous
Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than previous wave at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years
experience. 35
Q14. Med Rep Evaluation (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 • For panel 3 & 4, pls show horizontal
axis, scale 3-5 (major unit = 0.5)
CHECKED
ANS Med Rep Evaluation (Mean score) – VitaDairy MR across regions
(Based on total main HCPs who got visited in P3M by ANS med rep)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5
OVERALL MR SATISFACTION
Engages me in product discussion
Persuasive detailing
Trustworthy
Clear, well-structured brand messages
Well-equipped with scientific data
Knowledge about products &
competitors
Have in-depth nutritional knowledge
Appropriate frequency of visits
Courteous
Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than previous wave at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years
experience. 36
Q14. Med Rep Evaluation (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 • Panel 3 has 2 slides: Recoshare to
ANS brands & Recoshare to C&B
brands
CHECKED • Panel 1 has 2 slides:
• IMF Prime: subgroup brands
Reco Share to Diabetes brands (%) • IMF Specialty: by brands in lis
BY REGION (Based on total main HCPs) besides
OTHER SOUTH CENTRAL OTHER NORTH

TOTAL HCM-R1 HN-R7 R2 R3 R4 R5 R6 R8

W2'21 n=280 W2'21 n=50 W2'21 n=50 W2'21 n=30 W2'21 n=30 W2'21 n=30 W2'21 n=30 W2'21 n=30 W2'21 n=30
W1'21 n=280 W1'21 n=50 W1'21 n=50 W1'21 n=30 W1'21 n=30 W1'21 n=30 W1'21 n=30 W1'21 n=30 W1'21 n=30

Glucerna (Abbott) 72
72
lucose Control (Nestle) 9 15
7 12
ure Diecerna (Vinamilk) 8 5
10 9 7
etCare Gold (Nutifood) 5 4
4 6
re Diamond (Nutifood) 0 0
2 ▲ 3
Care Gold/ Diabet Care 5 4
Diamond (Nutifood) 6 8
vita Gold (VitaDairy) 0 0
0 0
Care Gold (Nutricare)
0 0
0 1
0 0
ax Diabet (Deltasun) 0 0
70 82 81 80 52 70 70 70
67 82 80 88 54 65 66 73
5 15 5 0 3 6 24
4 11 5 0 1 8 11
5 0 6 9 14 20 5
0 6 13 19 23 7
2 0 7 25 0 3 0
1 0 0 25 2 0 0
2 0 1 0 0 0 0
2 0 1 0 1 0 9 ▲
4 0 8 25 0 3 0
3 0 1 25 2 0 9 ▲
0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
1 0 1 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 1 0

General Practitioner/Endocrinologist/Nurse has at least 3 years Higher/Lower than previous wave at 90% c.l
37
experience. Q3. Reco share to Diabetes Brands
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 CHECKED
HCPs Profile (%)
TOTAL (Based on main HCPs)

SPECIALIZATION YEARS OF PRACTICE MEDICAL PRACTICE

50% 89%
25% 25%
44% 10% 1%
er t e 41% l l c
W2’21 on gis rs ita ita ni
ti ol
o Nu 16% sp sp c l i
cti in
(n=280)
pra ocr ho ho a te
al d ic te iv
n er En 3 to 5 6 to 10 11 to 30 ubl ir va Pr
Ge years years years P P

49% 94%
26% 25%
51% 5% 1%
ne
r ist rs
e l l c
W1’21 o log Nu 30% pita p
ti a l i ni
titi o 19% s s c
(n=280) r ac crin ho ho te
lp do lic te iva
ra En Pr
n e 3 to 5 6 to 10 11 to 30
Pu
b iva
Ge years years years Pr

General Practitioner/Endocrinologist/Nurse has at least 3 years S3. Specialization/S4. Years of Experience

experience. S2. Medical Practice Segment/S0c. HCPs ratings (for in-list)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 CHECKED
BY REGION
HCPs Profile (%)
(Based on main HCPs)

HCM (R1) HANOI (R7) R2 R3 R4 R5 R6 R8

W1'21 W2'21 W1'21 W2'21 W1'21 W2'21 W1'21 W2'21 W1'21 W2'21 W1'21 W2'21 W1'21 W2'21 W1'21 W2'21
Base 50 50 50 50 30 30 30 30 30 30 30 30 30 30 30 30
General
SPECIALIZATION practitioner 20 30 38 28 43 53 27 37 23 17 30 13 17 7 7 13
Endocrinologist 54 44 38 48 30 20 50 40 50 57 47 63 57 67 70 63
Nurse 26 26 24 24 27 27 23 23 27 27 23 23 27 27 23 23
Base 50 50 50 50 30 30 30 30 30 30 30 30 30 30 30 30
3-5 years 12 12 24 18 40 23 27 27 27 13 0 7 13 17 7 10
EXPERIENCE 6-10 years 28 46 32 28 37 57 33 37 30 63 17 30 40 67 27 30
More than 10
years 60 42 44 54 23 20 40 37 43 23 83 63 47 17 67 60
Base 50 50 50 50 30 30 30 30 30 30 30 30 30 30 30 30
MEDICAL Public Hospital 100 100 92 88 87 83 87 63 97 97 90 73 100 100 100 100
PRACTICE Private Hospital 0 0 8 12 7 10 13 37 3 0 10 27 0 0 0 0
Private Clinic 0 0 0 0 7 7 0 0 0 3 0 0 0 0 0 0

General Practitioner/Endocrinologist/Nurse has at least 3 years S3. Specialization/S4. Years of Experience 39

experience. S2. Medical Practice Segment/S0c. HCPs ratings (for in-list)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 CHECKED PANEL 4 ONLY
Diabetes Patients Pool
TOTAL (Based on Total HCPs)
W1’21 W2’21
(n=280) (n=280)

Number of monthly patient visits 650 67%

Number of monthly patient visits 562 68%
Number of targeted patient visits 436 Number of targeted patient visits 381
Number of targeted patient got reco 301 69% Number of targeted patient got reco
(Total patient visits n= 381)
261 69%
(Total patient visits n= 436)

79% Old patients 80% Old patients

21% New patients 20% New patients

Total Total

Active Reco 41 Active Reco 41

Reco when Asked 35 Reco when Asked 35
Approve when Asked 24 Approve when Asked 24

General Practitioner/Endocrinologist/Nurse has at least 3 years S8/S9. Number of patients. Q4/Q6/Q7. Target group contribution
experience. 40
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 CHECKED PANEL 4 ONLY
BY REGION
Diabetes Patients Pool
(Based on main Total HCPs)

HCM (R1) HANOI (R7) R2 R3 R4 R5 R6 R8

W1'21 W2'21 W1'21 W2'21 W1'21 W2'21 W1'21 W2'21 W1'21 W2'21 W1'21 W2'21 W1'21 W2'21 W1'21 W2'21
Base 50 50 50 50 30 30 30 30 30 30 30 30 30 30 30 30
NUMBER OF Total monthly patients visits
PATIENTS 794 620 557 464 620 528 619 795 664 519 743 531 622 518 545 545
VISITS Total monthly targeted visits 578 387 365 347 375 347 435 602 423 319 445 311 429 373 390 379
Total monthly targeted visits got reco 387 272 223 226 230 185 357 432 352 246 312 201 277 279 268 262
Total monthly targeted visits 578 387 365 347 375 347 435 602 423 319 445 311 429 373 390 379
% OF PATIENT
GROUPS Repeated patient 83 84 80 80 74 75 85 88 72 71 80 81 79 78 75 77
New patient 17 16 20 20 26 26 15 12 29 29 20 19 22 22 25 23
Active recommendation 38 36 25 25 40 40 49 49 41 44 45 45 59 71 45 33
Diabetes Reco Recommending when being asked
case (%) 36 37 46 44 42 38 33 36 28 29 29 31 22 16 40 43
Approving when being asked 26 27 29 31 19 22 18 16 32 26 26 24 19 13 15 24

General Practitioner/Endocrinologist/Nurse has at least 3 years S8/S9. Number of patients. Q4/Q6/Q7. Target group contribution
experience. 41
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 NOTE: for panel 1 (IMF), the
slides for:
IMF Prime brands
IMF Specialty brands
Med Rep’s Key Messages – Standardize Score (%)
Message for Glucerna (Based on total HCPs who got visitedNutren
in P3M by specific
Sure companies’ med rep)
Diabetes/ DiabetCare/ Diabet Care
TOTAL Message for Nutren Diabetes Diecerna
Glucerna (Abbott) Boost Glucose *DiabetCare Gold Diamond
(Vinamilk)
Control (Nestle) (Nutifood) (Nutifood)
Message for Sure Diecerna (n=280) (n=56) (n=77) (n=50) (n=22*)
Message for Diabetcare

Provide Immunoglobulins (IGG, IGA, IGM, IGD, IGFI, IGFII, IGE), helps strengthen
the resistance, high immune-enhancing factors 1 -2 2 1 -2

Contains FOS/INSULIN - soluble fiber – help slowing down sugar absorption,

reduces cholesterol absorption, enhances the development of intestinal bacteria,
supports digestive tract immunity, prevents constipation 8 -6 5 3 -10

Contains Lutein to support vision, against the effects of ultraviolet rays

-6 8 1 3 -6

Supplementing with 100% FOS soluble fiber helps to regenerate beneficial

bacteria, reducing constipation. Especially, it does not contain lactose to help
reduce diarrhea in people who do not have the habit of using milk, those who are 0 0 4 -2 -2
intolerant to lactose.

Supplementing with Insulin (ingredients found in royal jelly & propolis), Nano
Calcium micronutrients (Calcium Nano helps to absorb into bones more easily -7 0 10 4 -7
than regular Calcium), Vitamins and minerals to help diabetics and dieters protect
bones and joints to avoid brittle bones due to loss of substances & promote
metabolism to avoid loss of substances caused by diseases
General Practitioner/Endocrinologist/Nurse has at least 3 years 42
experience. STDEV.P 5.34 Q5d. Med Rep’s Aided Key Message (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
Strong points Neutral Weak points
 slides for:
IMF Prime brands
IMF Specialty brands
CHECKED
Med Rep’s Key Messages – Absolute Score (%)
Message for Glucerna (Based on total HCPs who got visited in P3M by specific companies’ med rep) DiabetCare/
TOTAL Message for Nutren Diabetes Nutren
Glucerna Diabetes/ Boost Sure Diecerna
DiabetCare/ Diabet Care DiabetCare
Gluvita/ Gluvita GluCare Gold
*DiabetCare Diamond Gold/ Diabet
Message for Sure Diecerna (Abbott) Glucose Control (Vinamilk) Gold (VitaDairy) (Nutricare)
Gold (Nutifood) (Nutifood) Care Diamond
(Nestle)
Message for Diabetcare (Nutifood)
(n=280) (n=56) (n=77) (n=50) (n=22*) (n=53) (n=4*) (n=7*)

Provide Immunoglobulins (IGG, IGA, IGM, IGD, IGFI, IGFII, IGE), helps strengthen
the resistance, high immune-enhancing factors 84 14 27 8 9 11 0 0

Contains FOS/INSULIN - soluble fiber – help slowing down sugar absorption,

reduces cholesterol absorption, enhances the development of intestinal bacteria,
86 9 29 10 0 9 0 0
supports digestive tract immunity, prevents constipation

Contains Lutein to support vision, against the effects of ultraviolet rays 76 23 26 10 5 11 0 0

Supplementing with 100% FOS soluble fiber helps to regenerate beneficial

bacteria, reducing constipation. Especially, it does not contain lactose to help 84 16 29 6 9 9 0 0
reduce diarrhea in people who do not have the habit of using milk, those who are
intolerant to lactose.

80 16 36 12 5 13 0 0
Supplementing with Insulin (ingredients found in royal jelly & propolis), Nano
Calcium micronutrients (Calcium Nano helps to absorb into bones more easily
than regular Calcium), Vitamins and minerals to help diabetics and dieters protect
bones and joints to avoid brittle bones due to loss of substances & promote
General Practitioner/Endocrinologist/Nurse
metabolism to avoid loss of substances causedhasbyatdiseases
least 3 years Higher/Lower than previous wave at 90% c.l 43
experience. Q5d. Med Rep’s Aided Key Message (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30 Outstanding key message among that specific brands
 • Panel 3: Maxvida
• Panel 4: Vidavance

CHECKED
Med Rep’s Key Messages – W2W Comparison (%)
Message for Glucerna (Based on total HCPs who got visited in P3M by specificDiabetCare/
companies’ med rep) DiabetCare/
TOTAL Message for Nutren Diabetes Nutren Diabetes/
Sure Diecerna Diabet Care Diamond DiabetCare Gold/ Gluvita/ Gluvita Gold G
Glucerna (Abbott) Boost Glucose DiabetCare Gold
(Vinamilk) (Nutifood) Diabet Care Diamond (VitaDairy)
Message for Sure Diecerna Control (Nestle) (Nutifood)
(Nutifood)
Message for Diabetcare
W1'21 n=280 W1'20 n=199 W1'21 n=62 W1'21 n=46 W1'21 n=15* W1'21 n=47 W1'21 n=0*
W2'21 n=280 W2'20 n=186 W2'21 n=77 W2'21 n=50 W2'21 n=22* W2'21 n=53 W2'21 n=4*
Provide Immunoglobulins (IGG, IGA, IGM, IGD, IGFI, 60 65 70 75 80 85 0905 10 15 20 25 0 10 20 30 40 0 0.5 1 0
IGFII, IGE), helps strengthen the resistance, high
immune-enhancing factors
Contains FOS/INSULIN - soluble fiber – help slowing
down sugar absorption, reduces cholesterol
absorption, enhances the development of intestinal
bacteria, supports digestive tract immunity, prevents
constipation
Contains Lutein to support vision, against the effects
of ultraviolet rays
Supplementing with 100% FOS soluble fiber helps to
regenerate beneficial bacteria, reducing constipation.
Especially, it does not contain lactose to help reduce
diarrhea in people who do not have the habit of using
milk, those who are intolerant to lactose.
Supplementing with Insulin (ingredients found in
royal jelly & propolis), Nano Calcium micronutrients
(Calcium Nano helps to absorb into bones more easily
than regular Calcium), Vitamins and minerals to help
diabetics and dieters protect bones and joints to
avoid brittle bones due to loss of substances &
promote metabolism to avoid loss of substances
caused by diseases

General Practitioner/Endocrinologist/Nurse has at least 3 years * Small base, for reference only 44
experience. Higher/Lower than previous wave at 90% c.l Q5d. Med Rep’s Aided Key Message (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 axis, scale 3-5 (major unit = 0.5)

Replicate for all brands – across panels

CHECKED
Factors Affecting ANS Recommendation (Mean Score) – GluCare Gold across regions
(Based on total HCPs who are aware of ANS brand)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5

Med Rep quality

Many supporting activities to HCPs

High quality product

Company that invests in science & clinical

proofs

Long heritage & credible company

Variety of products to support many

needs/full product portfolio
Value for money/Good price for good
quality

Products have no undesirable side-effects

Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than total at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 45
experience. Q9b. Brand Evaluation on Factors Affecting ANS Reco
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 axis, scale 3-5 (major unit = 0.5)

Replicate for all brands – across panels

CHECKED
Factors Affecting ANS Recommendation (Mean Score) – Natrumax Diabet across regions
(Based on total HCPs who are aware of ANS brand)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5

Med Rep quality

Many supporting activities to HCPs

High quality product

Company that invests in science & clinical

proofs

Long heritage & credible company

Variety of products to support many

needs/full product portfolio
Value for money/Good price for good
quality

Products have no undesirable side-effects

Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than total at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years 46
experience. Q9b. Brand Evaluation on Factors Affecting ANS Reco
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 • For panel 3 & 4, pls show horizontal
axis, scale 3-5 (major unit = 0.5)
CHECKED
ANS Med Rep Evaluation (Mean score) – Nutricare MR across regions
(Based on total main HCPs who got visited in P3M by ANS med rep)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5
OVERALL MR SATISFACTION
Well-equipped with scientific data
Engages me in product discussions
Clear, well-structured brand messages
In-depth nutritional knowledge
Appropriate frequency of visits
Knowledge about products &
competitors
Trustworthy
Persuasive detailing
Courteous
Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than previous wave at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years
experience. 47
Q14. Med Rep Evaluation (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30
 • For panel 3 & 4, pls show horizontal
axis, scale 3-5 (major unit = 0.5)

ANS Med Rep Evaluation (Mean score) – Deltasun MR across regions

(Based on total main HCPs who got visited in P3M by ANS med rep)
W1’21
W2’21 HCM vs. Total HN vs. Total R2 vs. Total R3 vs. Total R4 vs. Total R5 vs. Total R6 vs. Total R8 vs. Total
3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5 3 3.5 4 4.5 5
OVERALL MR SATISFACTION
Well-equipped with scientific data
Engages me in product discussions
Clear, well-structured brand messages
In-depth nutritional knowledge
Appropriate frequency of visits
Knowledge about products &
competitors
Trustworthy
Persuasive detailing
Courteous
Base: Total=280, HCM= HN = 50; R2=R3=R4=R5=R6=R8=30 Higher/Lower than nationwide at 90% c.l
Higher/Lower than previous wave at 90% c.l
General Practitioner/Endocrinologist/Nurse has at least 3 years
experience. 48
Q14. Med Rep Evaluation (SA)
RI (HCM) = R7 (HN) = 50; R2=R3=R4=R5=R6=R8=30